Search

Author/Creator Stein, Mark

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors. (10th December 2020)

Authors:
Shum, Elaine; Daud, Adil; Reilley, Matthew; Najjar, Yana; Thompson, John; Baranda, Joaquina; Donald Harvey, R; Leidner, Rom; Shields, Anthony; Cohen, Ezra; Cohen, Roger; Mita, Alain; Pant, Shubham; Stein, Mark; Chmielowski, Bartosz; Hu-Lieskovan, Siwen; Fleener, Catherine; Ding, Ying; Chollate, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A247
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors. (9th November 2020)

Authors:
Shum, Elaine; Daud, Adil; Reilley, Matthew; Najjar, Yana; Thompson, John; Baranda, Joaquina; Donald Harvey, R; Leidner, Rom; Shields, Anthony; Cohen, Ezra; Cohen, Roger; Mita, Alain; Pant, Shubham; Stein, Mark; Chmielowski, Bartosz; Hu-Lieskovan, Siwen; Fleener, Catherine; Ding, Ying; Chollate, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A432
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Issue 10275 (20th February 2021)

Authors:
Pal, Sumanta K; Tangen, Catherine; Thompson, Ian M; Balzer-Haas, Naomi; George, Daniel J; Heng, Daniel Y C; Shuch, Brian; Stein, Mark; Tretiakova, Maria; Humphrey, Peter; Adeniran, Adebowale; Narayan, Vivek; Bjarnason, Georg A; Vaishampayan, Ulka; Alva, Ajjai; Zhang, Tian; Cole, Scott; Plets, Mel...
Journal:
Lancet
Issue:
Volume 397:Issue 10275(2021)
Page Start:
695
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023. Issue 2 (23rd February 2023)

Authors:
Joshi, Monika; Tuanquin, Leonard; Zhu, Junjia; Walter, Vonn; Schell, Todd; Kaag, Matthew; Kilari, Deepak; Liao, Jiangang; Holder, Sheldon L; Emamekhoo, Hamid; Sankin, Alexander; Merrill, Suzzane; Zheng, Hong; Warrick, Joshua; Hauke, Ralph; Gartrel, Benjamin; Stein, Mark; Drabick, Joseph; Degraff,...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. DDIS-16. ONC201 IN COMBINATION WITH RADIATION EXHIBITS SYNERGISTIC EFFICACY IN HIGH GRADE GLIOMAS AND OTHER ADVANCED CANCERS. (5th November 2018)

Authors:
Tarapore, Rohinton; Jhawar, Sachin; Stein, Mark; Haffty, Bruce; Zloza, Andrew; Mueller, Sabine; Zhang, Jie; Amoroso, Francesca; Mills, Ian; Oster, Wolfgang; Allen, Joshua
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi72
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗